EGFR and lung carcinoma: However, whether and how STEP phosphatase contributes to the occurrence and development of tumor‐associated diseases, particularly the influence on the therapeutic effect of chemotherapeutic agents (such as EGFR‐TKIs applied in lung cancer), is still in the puzzle.